RED+BLUE STRATEGIES for QUEST DIAGNOSTICS INCORPORATED
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
H.R. 10545 - The Continuing Appropriations and Extensions Act, 2025- Issues related to funding government departments and agencies responsible for health care programs and support for a delay to certain cuts to laboratory payments covered by Medicare. Rules and regulations related to FDA's treatment of certain laboratory developed tests. Issues related to specific, federally-reimbursed drug testing protocols. H.R. 1835- The Saving Access to Laboratory Services Act - Issues related to the treatment of clinical labs in the Medicare program. Rules, regulations and guidance related to the end of the public health emergency and the treatment of Covid testing, pathology and other related issues. Issues related to testing for STDs. Issues related to testing for PFAS. Issues related to the Cancer Moonshot initiative and addressing ways to combat and prevent cancer.
| Lobbyist | Covered position, as disclosed |
|---|---|
| MEGAN HAUCK MARSHALL | — |
| MELANIE JAN NATHANSON | — |
Medicare/Medicaid MMM
H.R. 10545 - The Continuing Appropriations and Extensions Act, 2025- Issues related to funding government departments and agencies responsible for health care programs and support for a delay to certain cuts to laboratory payments covered by Medicare. Issues related to combatting the syphilis crisis in the United States and its impact on underserved communities. H.R. 4366 - Consolidated Appropriations and Other Extenders Act of 2024 - Issues related to maintaining support for laboratory programs and services for the upcoming fiscal year. H.R. 2882 - Further Consolidated Appropriations Act of 2024 - Issues related to funding of programs promulgated by the Department of Health and Human Services and its agencies, including CMS. Issues related to specific, federally-reimbursed drug testing protocols. H.R. 1835- The Saving Access to Laboratory Services Act - Issues related to the treatment of clinical labs in the Medicare program.
| Lobbyist | Covered position, as disclosed |
|---|---|
| MEGAN HAUCK MARSHALL | — |
| MELANIE JAN NATHANSON | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.